First Time Loading...

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 010 JPY -0.49% Market Closed
Updated: May 4, 2024

Takara Bio Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Takara Bio Inc
Operating Income Peer Comparison

Comparables:
2160
4587
2929
J
7774
S
4599

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Takara Bio Inc
TSE:4974
Operating Income
¥1.5B
CAGR 3-Years
-49%
CAGR 5-Years
-21%
CAGR 10-Years
-2%
GNI Group Ltd
TSE:2160
Operating Income
¥5.2B
CAGR 3-Years
44%
CAGR 5-Years
55%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Operating Income
¥6.8B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Pharma Foods International Co Ltd
TSE:2929
Operating Income
¥6B
CAGR 3-Years
39%
CAGR 5-Years
47%
CAGR 10-Years
48%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Operating Income
-¥155.3m
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
17%
S
StemRIM Inc
TSE:4599
Operating Income
¥142.4m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Takara Bio Inc's Operating Income?
Operating Income
1.5B JPY

Based on the financial report for Dec 31, 2023, Takara Bio Inc's Operating Income amounts to 1.5B JPY.

What is Takara Bio Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-2%

Over the last year, the Operating Income growth was -95%. The average annual Operating Income growth rates for Takara Bio Inc have been -49% over the past three years , -21% over the past five years , and -2% over the past ten years .